The Zhenan Bao Research Group at Stanford University developed and manufactured a photo-curable, directly patternable, stretchable, and highly conductive polymer that is ideal for bioelectronic applications, and stretchable electronic devices.
Chemical engineers at Stanford have developed miscible antifoams that are easy to incorporate and do not separate out from the target liquid during operation.
Researchers at Stanford University have identified a small molecule tryptase inhibitor for treatment of severe allergies. Mast cells are a part of the innate and adaptive immune response. Mast Cell activation results in release of granules containing tryptases.
Stanford researchers have developed a patented microscopy method which can provide chemical identification of molecular structures with radiation spectroscopy at nanometer or near-atomic scales, which is one of the most challenging problems in microscopy.
Stanford engineers have developed an optical modulator to enable low-cost and high spatial-resolution time-of-flight imaging and LiDAR with low-cost standard image sensors.
Stanford researchers in the WE3 and S3 Labs developed a cloud-based computation and predictive control platform for wastewater treatment facilities energy storage and energy generation. Wastewater treatment is energy and cost intensive.
Dr. Curt Scharfe and colleagues have developed RUSPseq, a method for next generation molecular testing originally conceived to diagnose metabolic disorders in newborns.
Robots will need sensory skins to safely interact with humans and navigate more complex environments than factory work cells. This invention is a new stretchable pneumatic sensor skin that can feel its surroundings and reach for objects in constrained environments.
Researchers at Stanford have developed a new path planning algorithm that enables autonomous multi-drone aerial surveys over large-scale environments. Their system solves the problem of finding routes over large areas in order to complete aerial survey tasks in reduced time.
Researchers at Stanford University have developed a rapid and sensitive bioluminescent assay for screening bacterial infections using enzyme-produced photo emission for detection of beta lactamase activity.
Multiplexed analysis of biological components is critical for classifying molecular subtypes of heterogeneous tumors to provide patient-specific therapies.